300 related articles for article (PubMed ID: 26574696)
21. Postoperative FDG-PET/CT staging in GIST: is there a benefit following R0 resection?
Hahn S; Bauer S; Heusner TA; Ebeling P; Hamami ME; Stahl A; Forsting M; Bockisch A; Antoch G
Eur J Radiol; 2011 Dec; 80(3):670-4. PubMed ID: 20970938
[TBL] [Abstract][Full Text] [Related]
22. Performance of F-18 FDG PET/CT for predicting malignant potential of gastrointestinal stromal tumors: A systematic review and meta-analysis.
Kim SJ; Lee SW
J Gastroenterol Hepatol; 2018 Mar; 33(3):576-582. PubMed ID: 28994187
[TBL] [Abstract][Full Text] [Related]
23. Placental-site trophoblastic tumor and fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography.
Çerçi SS; Erdemoglu E; Bozkurt KK; Yalçn Y; Erdemoglu E
Hell J Nucl Med; 2015; 18(3):264-7. PubMed ID: 26574698
[TBL] [Abstract][Full Text] [Related]
24. Correlation of measurements from diffusion weighted MR imaging and FDG PET/CT in GIST patients: ADC versus SUV.
Wong CS; Gong N; Chu YC; Anthony MP; Chan Q; Lee HF; Chu KM; Khong PL
Eur J Radiol; 2012 Sep; 81(9):2122-6. PubMed ID: 21955604
[TBL] [Abstract][Full Text] [Related]
25. Assessment of early response to imatinib 800 mg after 400 mg progression by ¹⁸F-fluorodeoxyglucose PET in patients with metastatic gastrointestinal stromal tumors.
Chacón M; Eleta M; Espindola AR; Roca E; Méndez G; Rojo S; Pupareli C
Future Oncol; 2015; 11(6):953-64. PubMed ID: 25760976
[TBL] [Abstract][Full Text] [Related]
26. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
27. Detection of occult primary tumors in patients with cervical metastases of unknown primary tumors: comparison of (18)F FDG PET/CT with contrast-enhanced CT or CT/MR imaging-prospective study.
Lee JR; Kim JS; Roh JL; Lee JH; Baek JH; Cho KJ; Choi SH; Nam SY; Kim SY
Radiology; 2015 Mar; 274(3):764-71. PubMed ID: 25405771
[TBL] [Abstract][Full Text] [Related]
28. Prospective evaluation of CECT and 18F-FDG-PET/CT in detection of hepatic metastases.
D'souza MM; Sharma R; Mondal A; Jaimini A; Tripathi M; Saw SK; Singh D; Mishra A; Tripathi RP
Nucl Med Commun; 2009 Feb; 30(2):117-25. PubMed ID: 19057427
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral heterogeneity of F-18 FDG uptake differentiates between gastrointestinal stromal tumors and abdominal malignant lymphomas on PET/CT.
Watabe T; Tatsumi M; Watabe H; Isohashi K; Kato H; Yanagawa M; Shimosegawa E; Hatazawa J
Ann Nucl Med; 2012 Apr; 26(3):222-7. PubMed ID: 22187313
[TBL] [Abstract][Full Text] [Related]
30. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
[TBL] [Abstract][Full Text] [Related]
31. Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules.
Ohno Y; Koyama H; Takenaka D; Nogami M; Maniwa Y; Nishimura Y; Ohbayashi C; Sugimura K
J Magn Reson Imaging; 2008 Jun; 27(6):1284-95. PubMed ID: 18504748
[TBL] [Abstract][Full Text] [Related]
32. Breast cancer with low FDG uptake: characterization by means of dual-time point FDG-PET/CT.
Zytoon AA; Murakami K; El-Kholy MR; El-Shorbagy E; Ebied O
Eur J Radiol; 2009 Jun; 70(3):530-8. PubMed ID: 18395387
[TBL] [Abstract][Full Text] [Related]
33. Body surface area adapted iopromide 300 mg/ml versus 370 mg/ml contrast medium injection protocol: influence on quantitative and clinical assessment in combined PET/CT.
Verburg FA; Apitzsch J; Lensing C; Kuhl CK; Pietsch H; Mottaghy FM; Behrendt FF
Eur J Radiol; 2013 Dec; 82(12):2348-52. PubMed ID: 24113432
[TBL] [Abstract][Full Text] [Related]
34. Assessment of relapse in patients with peritoneal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy using F-18-FDG-PET/CT.
Klumpp B; Schwenzer NF; Gatidis S; Koenigsrainer I; Koenigsrainer A; Beckert S; Mueller M; Claussen CD; Pfannenberg C
Rofo; 2014 Apr; 186(4):359-66. PubMed ID: 24683168
[TBL] [Abstract][Full Text] [Related]
35. Imaging and clinicopathologic features of esophageal gastrointestinal stromal tumors.
Winant AJ; Gollub MJ; Shia J; Antonescu C; Bains MS; Levine MS
AJR Am J Roentgenol; 2014 Aug; 203(2):306-14. PubMed ID: 25055264
[TBL] [Abstract][Full Text] [Related]
36. Integrated fluorine-18 fluorodeoxyglucose (18F-FDG) PET/CT compared to standard contrast-enhanced CT for characterization and staging of pulmonary tumors eligible for surgical resection.
Quaia E; Tona G; Gelain F; Lubin E; Pizzolato R; Boscolo E; Bussoli L
Acta Radiol; 2008 Nov; 49(9):995-1004. PubMed ID: 18651256
[TBL] [Abstract][Full Text] [Related]
37. F-18 FDG PET/CT in the diagnosis of fever of unknown origin.
Balink H; Collins J; Bruyn GA; Gemmel F
Clin Nucl Med; 2009 Dec; 34(12):862-8. PubMed ID: 20139818
[TBL] [Abstract][Full Text] [Related]
38. Response assessment of colorectal liver metastases with contrast enhanced CT/18F-FDG PET.
García Vicente AM; Domínguez Ferreras E; Sánchez Pérez V; Poblete García VM; Villa Guzmán JC; Jiménez Aragón F; Pineda Pineda MD; Molino Trinidad C; Soriano Castrejón Á
Eur J Radiol; 2013 Jun; 82(6):e255-61. PubMed ID: 23414715
[TBL] [Abstract][Full Text] [Related]
39. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
40. Physiologic FDG uptake in the ovary together with an abdominal wall leiomyoma mimicking metastasizing ovarian cancer on PET/CT imaging.
Schwarz EI; Ramach C; Mende KA; Strobel K
Clin Nucl Med; 2009 Apr; 34(4):249-50. PubMed ID: 19300062
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
